RedHill Biopharma reported $800K in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 30M 336M Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
Cronos Group USD 1.03B 72.12M Jun/2026
RedHill Biopharma USD 1000K 4M Sep/2026